Hypermethylation of RASSF1A, CCDN2, HIN1 and APC correlates mainly with HR+ breast cancer, whereas hypermethylation of CDH1 and CDH13 is more frequent in TNBC patients (77). This evidence concerns the gene SCGB3A1 and breast carcinoma.